Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18499278 | 1.00 | TSHR (0.57) | TSHRALDH1A1MAPTRAD52NPSR1 | |
| SCHEMBL16217695 | 1.00 | TSHR (0.57) | TSHRALDH1A1MAPTRAD52NPSR1 | |
| SCHEMBL16217704 | 1.00 | TSHR (0.57) | TSHRALDH1A1MAPTRAD52NPSR1 | |
| SCHEMBL16217694 | 1.00 | TSHR (0.57) | TSHRALDH1A1MAPTRAD52NPSR1 | |
| SCHEMBL14886410 | 0.98 | TSHR (0.53) | TSHRALDH1A1MAPTRAD52NPSR1 | |
| SCHEMBL18499281 | 0.94 | TSHR (0.56) | TSHRALDH1A1MAPTRAD52NPSR1 | |
| SCHEMBL21802368 | 0.94 | TSHR (0.67) | TSHRALDH1A1RAD52NPSR1NAAA | |
| SCHEMBL16736012 | 0.94 | TSHR (0.67) | TSHRALDH1A1RAD52NPSR1NAAA | |
| SCHEMBL17973526 | 0.92 | TSHR (0.50) | TSHRALDH1A1MAPTRAD52NPSR1 | |
| SCHEMBL19184682 | 0.92 | TSHR (0.50) | TSHRALDH1A1MAPTRAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3848402-A1 | INK AND COATING FORMULATIONS AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME | Sirrus, Inc. (US) | 2021-07-14 | — | — | EP | disclosed |
| US-20210179892-A1 | COMPOSITE AND LAMINATE ARTICLES AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME | SIRRUS INC (US) | 2021-06-17 | — | — | US | disclosed |
| US-10913875-B2 | Composite and laminate articles and polymerizable systems for producing the same | SIRRUS, INC. (US) | 2021-02-09 | — | — | US | disclosed |
| US-10894856-B2 | Polyurethane-vinyl hybrid polymers, methods of making them and their use | BASF SE (DE) | 2021-01-19 | — | — | US | disclosed |
| US-10611861-B2 | Multifunctional monomers, methods for making multifunctional monomers, polymerizable compositions and products formed thereform | NIPPON SHOKUBAI CO., LTD. (JP) | 2020-04-07 | — | — | US | disclosed |
| US-10604601-B2 | Multifunctional monomers, methods for making multifunctional monomers, polymerizable compositions and products formed therefrom | SIRRUS, INC. (US) | 2020-03-31 | — | — | US | disclosed |
| EP-3626784-A1 | INK AND COATING FORMULATIONS AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME | Sirrus, Inc. (US) | 2020-03-25 | — | — | EP | disclosed |
| WO-2019195366-A1 | HETEROGENEOUS CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS | SIRRUS, INC. (US) | 2019-10-10 | — | — | WO | disclosed |
| US-20190256639-A1 | POLYURETHANE-VINYL HYBRID POLYMERS, METHODS OF MAKING THEM AND THEIR USE | BASF SE (DE) | 2019-08-22 | — | — | US | disclosed |
| US-20180222839-A1 | HETEROGENEOUS CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS | SIRRUS, INC. | 2018-08-09 | — | — | US | disclosed |
| US-9181365-B2 | Methods for activating polymerizable compositions, polymerizable systems, and products formed thereby | SIRRUS, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| US-9181365-B2 | Methods for activating polymerizable compositions, polymerizable systems, and products formed thereby | SIRRUS, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150104660-A1 | INK COATING FORMULATIONS AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME | SIRRUS, INC. (US) | 2015-04-16 | — | — | US | disclosed |
| US-20150104660-A1 | INK COATING FORMULATIONS AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME | SIRRUS, INC. (US) | 2015-04-16 | — | — | US | disclosed |
| US-20150073110-A1 | METHODS FOR ACTIVATING POLYMERIZABLE COMPOSITIONS, POLYMERIZABLE SYSTEMS, AND PRODUCTS FORMED THEREBY | NIPPON SHOKUBAI CO., LTD. (JP) | 2015-03-12 | — | — | US | disclosed |
| US-20150073110-A1 | METHODS FOR ACTIVATING POLYMERIZABLE COMPOSITIONS, POLYMERIZABLE SYSTEMS, AND PRODUCTS FORMED THEREBY | NIPPON SHOKUBAI CO., LTD. (JP) | 2015-03-12 | — | — | US | disclosed |
| US-20150056879-A1 | COMPOSITE AND LAMINATE ARTICLES AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20150056879-A1 | COMPOSITE AND LAMINATE ARTICLES AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20140329980-A1 | MULTIFUNCTIONAL MONOMERS, METHODS FOR MAKING MULTIFUNCTIONAL MONOMERS, POLYMERIZABLE COMPOSTIONS AND PRODUCTS FORMED THEREFORM | SIRRUS, INC. | 2014-11-06 | — | — | US | disclosed |
| US-20140329980-A1 | MULTIFUNCTIONAL MONOMERS, METHODS FOR MAKING MULTIFUNCTIONAL MONOMERS, POLYMERIZABLE COMPOSTIONS AND PRODUCTS FORMED THEREFORM | SIRRUS, INC. | 2014-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10604601-B2 | Multifunctional monomers, methods for making multifunctional monomers, polymerizable compositions and products formed therefrom | BHMT2, MACF1, BHMT | TSHR 4885/4885ALDH1A1 560/4885MAPT 996/4885 |
| US-20140329980-A1 | MULTIFUNCTIONAL MONOMERS, METHODS FOR MAKING MULTIFUNCTIONAL MONOMERS, POLYMERIZABLE COMPOSTIONS AND PRODUCTS FORMED THEREFORM | BHMT2, MTHFD2, BHMT | TSHR 4885/4885ALDH1A1 601/4885MAPT 851/4885 |
| US-20180222839-A1 | HETEROGENEOUS CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS | NOTUM, CES1, ADH5 | TSHR 2652/4885ALDH1A1 137/4885MAPT 3780/4885 |
| US-10611861-B2 | Multifunctional monomers, methods for making multifunctional monomers, polymerizable compositions and products formed thereform | MACF1, BHMT2, MTHFD2 | TSHR 4885/4885ALDH1A1 531/4885MAPT 1346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.